CAMLINFINEBSECamlin Fine Sciences LtdHighNeutral
Announced Tue, 26 May · 17:03 IST

Change in Management

Management Changes View source PDF

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹121.50
prior close
₹120.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+3.9+4.2+6.9+0.8-2.9-2.1-3.6-1.2+4.7+12.8+6.9+5.2
Up moveDown movePending
AI summary

Camlin Fine Sciences reported its FY2026 audited financial results. Standalone revenue fell to Rs. 83,791.82 lakh from Rs. 88,649.13 lakh in FY2025, with standalone net loss of Rs. 1,299.66 lakh. Consolidated results showed a net loss of Rs. 3,198.61 lakh from continuing operations. Key management changes include the appointment of Mr. Pankaj Pandey as new CFO effective August 18, 2026, with current CFO Mr. Santosh Parab being re-designated as President – Strategy and Global CFO. The company also completed acquisition of Vinpai S.A. (now 83.82% owned) and saw liquidation of CFS Europe SpA in Italy. The 33rd AGM is scheduled for August 11, 2026.

Likely market impact

The CFO transition appears to be an internal reorganization rather than a resignation, as the current CFO remains with an elevated role. The significant losses and revenue decline may concern investors, though the Vinpai acquisition and discontinued operations write-offs provide context.